MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Sundry Debtors | ₹1,538 Cr | ₹848 Cr | ₹576 Cr | ₹388 Cr | ₹331 Cr |
What is the latest Sundry Debtors ratio of MANKIND PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2025 | ₹1,538 Cr |
Mar2024 | ₹848 Cr |
Mar2023 | ₹576 Cr |
Mar2022 | ₹388 Cr |
Mar2021 | ₹331 Cr |
How is Sundry Debtors of MANKIND PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2025 | ₹1,538 Cr | 81.35 | |
Mar2024 | ₹848 Cr | 47.16 | |
Mar2023 | ₹576 Cr | 48.50 | |
Mar2022 | ₹388 Cr | 17.41 | |
Mar2021 | ₹331 Cr | - |
Compare Sundry Debtors of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹100,552.3 Cr | -6.2% | -3.1% | 23.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,917.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,982.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,306.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹121,442.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,752.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -6.2% |
-3.1% |
23.6% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses